APA (7th ed.) Citation

Bermúdez-Barrezueta, L., Matías del Pozo, V., Marugán-Miguelsanz, J. M., López, E. I., Uribe-Reina, P., Romero del Hombrebueno, Y., . . . Pino-Vázquez, M. A. (2025). Universal administration of nirsevimab in infants: An analysis of hospitalisations and paediatric intensive care unit admissions for RSV-associated lower respiratory tract infections. European Journal of Pediatrics, 184(6), 1. https://doi.org/10.1007/s00431-025-06125-5

Chicago Style (17th ed.) Citation

Bermúdez-Barrezueta, Lorena, et al. "Universal Administration of Nirsevimab in Infants: An Analysis of Hospitalisations and Paediatric Intensive Care Unit Admissions for RSV-associated Lower Respiratory Tract Infections." European Journal of Pediatrics 184, no. 6 (2025): 1. https://doi.org/10.1007/s00431-025-06125-5.

MLA (9th ed.) Citation

Bermúdez-Barrezueta, Lorena, et al. "Universal Administration of Nirsevimab in Infants: An Analysis of Hospitalisations and Paediatric Intensive Care Unit Admissions for RSV-associated Lower Respiratory Tract Infections." European Journal of Pediatrics, vol. 184, no. 6, 2025, p. 1, https://doi.org/10.1007/s00431-025-06125-5.